Gregory S. Ducker

5.3k total citations · 1 hit paper
29 papers, 3.2k citations indexed

About

Gregory S. Ducker is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Gregory S. Ducker has authored 29 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Gregory S. Ducker's work include PI3K/AKT/mTOR signaling in cancer (9 papers), Epigenetics and DNA Methylation (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Gregory S. Ducker is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (9 papers), Epigenetics and DNA Methylation (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Gregory S. Ducker collaborates with scholars based in United States, Austria and Zimbabwe. Gregory S. Ducker's co-authors include Joshua D. Rabinowitz, Raphael J. Morscher, Kevan M. Shokat, Jonathan M. Ghergurovich, Xin Teng, Li Chen, Hsin‐Jung Li, Zemer Gitai, Yibin Kang and Mark Esposito and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

Gregory S. Ducker

27 papers receiving 3.2k citations

Hit Papers

One-Carbon Metabolism in Health and Disease 2016 2026 2019 2022 2016 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory S. Ducker United States 17 2.1k 763 494 284 277 29 3.2k
Jonathan M. Ghergurovich United States 15 1.9k 0.9× 1.2k 1.5× 128 0.3× 602 2.1× 364 1.3× 18 3.1k
Elena R. García–Trevijano Spain 28 1.4k 0.6× 257 0.3× 571 1.2× 174 0.6× 264 1.0× 56 2.7k
Oliver D.K. Maddocks United Kingdom 27 3.5k 1.7× 2.2k 2.9× 223 0.5× 347 1.2× 775 2.8× 42 4.9k
Shigetaka Kitajima Japan 40 2.7k 1.3× 466 0.6× 298 0.6× 722 2.5× 542 2.0× 97 4.3k
Youichiro Wada Japan 31 1.6k 0.8× 704 0.9× 129 0.3× 637 2.2× 361 1.3× 80 3.2k
Hubert de Verneuil France 43 3.8k 1.8× 386 0.5× 609 1.2× 309 1.1× 274 1.0× 145 5.1k
Gary J. Litherland United Kingdom 21 1.1k 0.5× 323 0.4× 582 1.2× 149 0.5× 194 0.7× 42 2.1k
Yaoqin Gong China 40 3.5k 1.6× 951 1.2× 219 0.4× 663 2.3× 781 2.8× 146 5.2k
Oliver Stehling Germany 27 2.2k 1.0× 169 0.2× 173 0.4× 157 0.6× 169 0.6× 42 3.5k
Yue Huang China 34 2.1k 1.0× 330 0.4× 123 0.2× 256 0.9× 744 2.7× 101 3.6k

Countries citing papers authored by Gregory S. Ducker

Since Specialization
Citations

This map shows the geographic impact of Gregory S. Ducker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory S. Ducker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory S. Ducker more than expected).

Fields of papers citing papers by Gregory S. Ducker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory S. Ducker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory S. Ducker. The network helps show where Gregory S. Ducker may publish in the future.

Co-authorship network of co-authors of Gregory S. Ducker

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory S. Ducker. A scholar is included among the top collaborators of Gregory S. Ducker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory S. Ducker. Gregory S. Ducker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bott, Alex J., et al.. (2025). SLC7A5 is required for cancer cell growth under arginine-limited conditions. Cell Reports. 44(1). 115130–115130. 4 indexed citations
2.
Ducker, Gregory S., et al.. (2025). Hyperlipidemia drives tumor growth in a mouse model of obesity-accelerated breast cancer growth. Cancer & Metabolism. 13(1). 39–39. 1 indexed citations
3.
Stanley, Claire E., et al.. (2024). Phospholipid isotope tracing suggests β-catenin-driven suppression of phosphatidylcholine metabolism in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1869(6). 159514–159514. 2 indexed citations
4.
Cluntun, Ahmad A., Thirupura S. Shankar, Ling Jing, et al.. (2024). Enhancing mitochondrial pyruvate metabolism ameliorates ischemic reperfusion injury in the heart. JCI Insight. 9(21).
5.
Cluntun, Ahmad A., Thirupura S. Shankar, Ling Jing, et al.. (2024). Enhancing mitochondrial pyruvate metabolism ameliorates ischemic reperfusion injury in the heart. JCI Insight. 9(17). 9 indexed citations
6.
McBride, Matthew J., Zhaoyue Zhang, Tara TeSlaa, et al.. (2024). Glycine homeostasis requires reverse SHMT flux. Cell Metabolism. 36(1). 103–115.e4. 29 indexed citations
7.
Li, Albert M., Gregory S. Ducker, Yang Li, et al.. (2020). Metabolic Profiling Reveals a Dependency of Human Metastatic Breast Cancer on Mitochondrial Serine and One-Carbon Unit Metabolism. Molecular Cancer Research. 18(4). 599–611. 58 indexed citations
8.
Panic, Vanja, Stephanie Pearson, Trevor S. Tippetts, et al.. (2020). Mitochondrial pyruvate carrier is required for optimal brown fat thermogenesis. eLife. 9. 47 indexed citations
9.
Ducker, Gregory S., Leah K. Billingham, Carlos A. Martínez, et al.. (2019). Serine Metabolism Supports Macrophage IL-1β Production. Cell Metabolism. 29(4). 1003–1011.e4. 251 indexed citations
10.
Chamberlain, Chester E., Michael S. German, Katherine Yang, et al.. (2018). A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors. Molecular Cancer Therapeutics. 17(12). 2702–2709. 34 indexed citations
11.
Mues, Marsilius, Anica M. Wandler, Milou Tenhagen, et al.. (2018). Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy. PLoS ONE. 13(5). e0193849–e0193849. 13 indexed citations
12.
Rodan, Lance H., Gregory S. Ducker, Didem Demirbas, et al.. (2018). 5,10-methenyltetrahydrofolate synthetase deficiency causes a neurometabolic disorder associated with microcephaly, epilepsy, and cerebral hypomyelination. Molecular Genetics and Metabolism. 125(1-2). 118–126. 14 indexed citations
13.
Morscher, Raphael J., Gregory S. Ducker, Hsin‐Jung Li, et al.. (2018). Mitochondrial translation requires folate-dependent tRNA methylation. Nature. 554(7690). 128–132. 190 indexed citations
14.
Chen, Li, Gregory S. Ducker, Wenyun Lu, Xin Teng, & Joshua D. Rabinowitz. (2017). An LC-MS chemical derivatization method for the measurement of five different one-carbon states of cellular tetrahydrofolate. Analytical and Bioanalytical Chemistry. 409(25). 5955–5964. 36 indexed citations
15.
Ducker, Gregory S., Li Chen, Raphael J. Morscher, et al.. (2016). Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway. Cell Metabolism. 23(6). 1140–1153. 323 indexed citations
16.
Pourdehnad, Michael, Morgan Truitt, Imran Siddiqi, et al.. (2013). Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers. Proceedings of the National Academy of Sciences. 110(29). 11988–11993. 204 indexed citations
17.
Ducker, Gregory S., Chloé E. Atreya, Jeff Simko, et al.. (2013). Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors. Oncogene. 33(12). 1590–1600. 75 indexed citations
18.
Atreya, Chloé E., Gregory S. Ducker, Morris E. Feldman, et al.. (2012). Combination of ATP-competitive mammalian target of rapamycin inhibitors with standard chemotherapy for colorectal cancer. Investigational New Drugs. 30(6). 2219–2225. 15 indexed citations
19.
Ducker, Gregory S., et al.. (2011). The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile. Proceedings of the National Academy of Sciences. 108(37). 15201–15206. 90 indexed citations
20.
Okuzumi, Tatsuya, et al.. (2010). Synthesis and evaluation of indazole based analog sensitive Akt inhibitors. Molecular BioSystems. 6(8). 1389–1402. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026